FDA Drug Recalls

Recalls / Class II

Class IID-0495-2017

Product

Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07

Brand name
Duopa
Generic name
Carbidopa And Levodopa
Active ingredients
Carbidopa Hydrate, Levodopa
Route
Enteral
NDC
0074-3012
FDA application
NDA203952
Affected lot / code info
Lots: 1055692, Expiration Date (Frozen) 06/01/2018 1057881, Expiration Date (Frozen) 06/02/2018 1060138, Expiration Date (Frozen) 06/13/2018 1060140, Expiration Date (Frozen) 06/15/2018 1061258, Expiration Date (Frozen) 06/17/2018 1061262, Expiration Date (Frozen) 06/30/2018 1063033, Expiration Date (Frozen) 07/14/2018

Why it was recalled

Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life

Recalling firm

Firm
AbbVie Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
1 N Waukegan Rd, N/A, North Chicago, Illinois 60064-1802

Distribution

Quantity
4021 cartons, 7 100-mL cassettes each
Distribution pattern
TN and IL

Timeline

Recall initiated
2017-01-13
FDA classified
2017-02-27
Posted by FDA
2017-03-08
Terminated
2019-03-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0495-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Duopa · FDA Drug Recalls